Posts in Category: Biopharmaceutical

How Dr. Dov Rand Helps Patients Through An Integrative Approach To Medicine

Dr. Rand is a medical doctor that provides services to people suffering from age-related disorders. Dr. Dov Rand is very knowledgeable about hormone therapy, healthy eating, and exercise. He founded Health Aging Medical Center where he is the president. Patients who go to his center learn about innovative treatments to help with symptoms such as erectile dysfunction, menopause, and traumatic brain injury.

He says that patients often come in with a wide range of symptoms that, if left untreated, will eventually become debilitating. Dr. Dov Rand says that many patients aren’t aware of all the newer treatments that can help them lead better and more productive lives. He says hormone therapy is very effective, especially when combined with exercise and nutritional supplements including IV treatments. He says that there are emotional and psychological barriers that keep people from making better decisions about their diets and exercise plans.

The central aspect of Dr. Dov Rand’s treatment is integrative medicine. The idea is that if a therapy works with the body’s natural immune system than the best results will be achieved. To do this requires accurate information about the condition of the patient he says. He does thorough testing of each patient including blood tests, physical exams, testing for genetic markers, and talking to his patient about what they eat and what type of exercises they like doing.

For men, Dr. Dov Rand says that erectile dysfunction is a common occurrence as they age. They often have other symptoms as well like fatigue, stress, unhealthy weight, or insomnia. He says that to solve these issues means getting to the source of what is causing them. The immune system plays a big role and can be significantly helped through good nutrition, plenty of exercise, and diet. Eating habits and being overweight are the two most difficult things to tackle to help erectile dysfunction he says.

Dr. Dov Rand says that he helps patients retrain their eating habits by providing them with support. His staff is knowledgable about working through these issues with patients and getting them committed to a healthy lifestyle. He also works to make sure each of his patients incorporates a healthy lifestyle into their daily routines.

Find more information about Dr. Rand´s medical method at

Curing Rare Diseases with Amicus Therapeutics

Amicus Therapeutics, Inc. is a leading new frontier global biotechnology company based in Cranbury, New Jersey. This innovative company researches new discovery findings, the development, and adopting therapies for devastating rare and orphan diseases. Amicus Therapeutics has a vigorous line of one-of-a-kind small molecules called ‘pharmacological chaperones.’ The chaperones provide dual-treatment to bind, stabilize and increase the activity of a patient’s own deformed enzymes to potentially improve enzyme replacement therapy outcome.


Amicus Therapeutics, Inc., research and development processes began as a result of Megan Crowley, who was diagnosed with Pompe disease which she had been suffering with since the age of one. Pompe is a progressive muscle and respiratory weakening disease with a high mortality rate. Megan’s father, John Crowley is now the CEO of this biotechnology company which has a pipeline of therapies for human genetic diseases like his daughter has. Mr. Crowley is determined to find a cure for his daughter and many others who suffer from rare, unexplored diseases ( His quest has made Amicus Therapeutics a leader for the drug industry and has made them champions in the development of new medical treatments and programs.


Fabry is also an early age disease that affects millions around the world, just like the Pompe disease. Fabry disease leads to progressive, irreversible organ damage, typically involving the nervous, cardiac, and renal systems, as well as multiple other tissues. Both diseases require daily medical assistance to manage and control the complications of these devastating diseases affecting multiple organ systems. To find a cure for the Fabry disease, the Pompe disease, and other chronic diseases, Amicus Therapeutics is investigating enzyme replacement therapy, influencing chaperone advanced replacement therapy, taking a lead in the clinical development of topical medicine to treat genetic connective tissue disorders, including investigating many other scientific first treatments and discovery programs.


Amicus Therapeutics is leading the fight in developing a topical therapy for the treatment of lesions and blisters that appear on the skin and in some cases on the lining of other body organs. This rare, chronic disease is known as Epidermolysis Bullosa. Epidermolysis Bullosa can potentially become disfiguring, and in some cases fatal. Amicus Therapeutics has also taken the lead recently in promising finds for the underlying cause of muscle damage and weakness in Pompe patients. This pioneering company has a three-fold promise, which is to remain at the forefront of therapies for rare and orphan diseases, to build long-term value for stakeholders and to foster teamwork and respect for each individual’s contribution.